Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastoma

14 Oct 2013

Abstract excerpt

// Yoshinari Shinsato 1,2 , Tatsuhiko Furukawa 2 , Shunji Yunoue 1 , Hajime Yonezawa 1 , Kentarou Minami 2,3 , Yukihiko Nishizawa 2,3 , Ryuji Ikeda 3 , Kohichi Kawahara 2 , Masatatsu Yamamoto 2 , Hirofumi Hirano 1 , Hiroshi Tokimura 1 , and Kazunori Arita 1 1 Department of Neurosurgery, Graduate School of Medical and Dental Sciences Kagoshima University, Kagoshima, Japan; 2 Department of Molecular Oncology,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to DNA Repair Mechanisms
Share to Glioma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24259277
DOI: 10.18632/oncotarget.1302

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastomaPMID 24259277Read ↗

Characterization of Temozolomide Resistance Using a Novel Acquired Resistance Model in Glioblastoma Cell LinesSemantic proximity Read ↗

Potential Strategies Overcoming the Temozolomide Resistance for GlioblastomaSemantic proximity Read ↗

Mechanisms of temozolomide resistance in glioblastoma - a comprehensive reviewSemantic proximity Read ↗

A multifaceted review of temozolomide resistance mechanisms in glioblastoma beyond O-6-methylguanine-DNA methyltransferaseSemantic proximity Read ↗

Research progress of drug resistance mechanism of temozolomide in the treatment of glioblastomaSemantic proximity Read ↗

The expression of mismatch repair proteins MLH1, MSH2 and MSH6 correlates with the Ki67 proliferation index and survival in patients with recurrent glioblastomaSemantic proximity Read ↗

DNA methylation remodeling in temozolomide resistant recurrent glioblastoma: comparing epigenetic dynamics in vitro and in vivoSemantic proximity Read ↗

Problems of glioblastoma multiforme drug resistanceSemantic proximity Read ↗

Temozolomide resistance in glioblastoma multiformeSemantic proximity Read ↗

Variations in DNA Repair Genes and Intratumoral Genetic Heterogeneity in Temozolomide-Resistant Glioblastoma.Semantic proximity Read ↗

Mechanisms of Resistance to Current Glioblastoma TherapiesSemantic proximity Read ↗

Promoter methylation and expression of <i>MGMT</i> and the DNA mismatch repair genes <i>MLH1, MSH2, MSH6</i> and <i>PMS2</i> in paired primary and recurrent glioblastomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.